Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

C-reactive protein as a significant prognostic factor for stage IV gastric cancer patients.

Baba H, Kuwabara K, Ishiguro T, Hatano S, Matsuzawa T, Fukuchi M, Kumagai Y, Ishibashi K, Mochiki E, Ishida H.

Anticancer Res. 2013 Dec;33(12):5591-5.

PMID:
24324103
2.

C-reactive protein is a negative independent factor in patients with stage IV colorectal cancer undergoing oxaliplatin-based chemotherapy.

Fukuchi M, Kuwabara K, Tsuji Y, Baba H, Ishibashi K, Chika N, Hatano S, Matsuzawa T, Kumamoto K, Kumagai Y, Mochiki E, Ishida H.

Anticancer Res. 2013 Nov;33(11):5051-5.

PMID:
24222149
3.

The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.

Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T.

Eur J Cancer. 2015 Mar;51(5):610-9. doi: 10.1016/j.ejca.2015.01.002. Epub 2015 Jan 21.

PMID:
25618827
4.

[Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].

Kiliç T, Ural E, Oner G, Sahin T, Kiliç M, Yavuz S, Kanko M, Kahraman G, Bildirici U, Berki KT, Ural D.

Anadolu Kardiyol Derg. 2009 Aug;9(4):280-9. Turkish.

5.

Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.

Bedke J, Chun FK, Merseburger A, Scharpf M, Kasprzyk K, Schilling D, Sievert KD, Stenzl A, Kruck S.

BJU Int. 2012 Dec;110(11 Pt B):E771-7. doi: 10.1111/j.1464-410X.2012.11642.x. Epub 2012 Nov 7.

6.

Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.

Espín F, Bianchi A, Llorca S, Feliu J, Palomera E, García O, Remon J, Suñol X.

Eur J Surg Oncol. 2012 Jun;38(6):497-502. doi: 10.1016/j.ejso.2012.01.012. Epub 2012 Mar 23.

PMID:
22445061
7.

Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.

Chang CC, Sun CF, Pai HJ, Wang WK, Hsieh CC, Kuo LM, Wang CS.

Chang Gung Med J. 2010 May-Jun;33(3):301-12.

8.

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer.

Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, Kim KH, Han JY, Kim HJ.

BMC Cancer. 2009 May 20;9:155. doi: 10.1186/1471-2407-9-155.

9.

Improvement of high-sensitivity inflammation-based Glasgow prognostic score by gastrectomy is a favorable prognostic factor in patients with gastric cancer.

Takeno S, Hashimoto T, Shibata R, Maki K, Shiwaku H, Yamana I, Yamashita R, Yamashita Y.

Anticancer Res. 2014 Oct;34(10):5695-702.

PMID:
25275076
10.

Is C-reactive protein a prognostic factor of colorectal cancer?

Shiu YC, Lin JK, Huang CJ, Jiang JK, Wang LW, Huang HC, Yang SH.

Dis Colon Rectum. 2008 Apr;51(4):443-9. doi: 10.1007/s10350-007-9133-z. Epub 2008 Jan 3.

PMID:
18172726
11.

Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?

Correia LC, Lima JC, Rocha MS, D'Oliveira Junior A, Péricles Esteves J.

Clin Chim Acta. 2007 Jan;375(1-2):124-8. Epub 2006 Jun 29.

PMID:
16916502
12.

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.

Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, Sano T, Yamaguchi T.

Br J Cancer. 2012 Jul 10;107(2):275-9. doi: 10.1038/bjc.2012.262. Epub 2012 Jun 19.

13.

The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage.

Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Kurumatani N, Nakajima Y.

Ann Surg Oncol. 2013 Aug;20(8):2647-54. doi: 10.1245/s10434-013-2926-5. Epub 2013 Mar 6.

PMID:
23463091
14.

Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer.

Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC.

Am J Surg. 2012 Sep;204(3):294-9. doi: 10.1016/j.amjsurg.2011.10.015. Epub 2012 Mar 22.

PMID:
22444831
15.

Serum C-reactive protein levels predict survival in hepatocellular carcinoma.

Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M.

Liver Int. 2007 Oct;27(8):1091-7.

PMID:
17845537
16.

Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.

Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, Na SH, Hwang SS.

J Crit Care. 2011 Jun;26(3):287-94. doi: 10.1016/j.jcrc.2010.10.007. Epub 2010 Dec 3.

PMID:
21129911
17.

Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.

Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A.

Anticancer Res. 1997 Jul-Aug;17(4B):2903-6.

PMID:
9329559
18.

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma.

Oh BS, Jang JW, Kwon JH, You CR, Chung KW, Kay CS, Jung HS, Lee S.

BMC Cancer. 2013 Feb 15;13:78. doi: 10.1186/1471-2407-13-78.

19.

[Prognostic significance of metastatic lymph nodes ratio in patients with T2-T3 stage gastric cancer].

Feng RH, Zhu ZG, Yan M, Chen J, Xiang M, Yin HR, Lin YZ.

Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Sep;10(5):431-5. Chinese.

PMID:
17851782
20.

Prognostic significance of host- and tumor-related factors in patients with gastric cancer.

Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C, Kusunoki M.

World J Surg. 2010 Feb;34(2):285-90. doi: 10.1007/s00268-009-0302-1.

PMID:
19997918

Supplemental Content

Support Center